Influenza vaccine responses differ between young children previously exposed to influenza antigens via infection

Annette Fox1,2, Annette Alafaci3, Louise Carolan4

  • 1WHO Collaborating Centre for Reference and Research on Influenza Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. annette.fox@unimelb.edu.au.

Insights

Influenza infection in early childhood may prime better antibody responses to A(H3N2) vaccination than prior vaccination. This pilot study found higher antibody titres and seroconversion rates after vaccination in children with a history of influenza A(H3N2) infection.

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • Annual influenza vaccination is recommended for children.
  • The impact of early life influenza exposure (infection vs. vaccination) on subsequent immunity is not well understood.
  • This study investigates how prior influenza A(H3N2) infection versus vaccination influences immune responses to subsequent influenza vaccination in young children.

Purpose of the Study:

  • To examine the effect of early life influenza A(H3N2) infection versus vaccination on subsequent antibody responses to influenza vaccination.
  • To compare antibody titres and seroconversion rates after vaccination in children with different prior influenza exposure histories.

Main Methods:

  • Pilot study involving 19 children aged 6-60 months in Australia (2019-2021).
  • Plasma collected pre- and post-vaccination over up to three years.
  • Antibody titres measured using hemagglutination inhibition (HI), neuraminidase inhibition (NI) assays, and ELISA.
  • Children classified based on prior vaccination or influenza A(H3N2) infection history.

Main Results:

  • Post-vaccination antibody titres and titre-rises against A(H3N2) were significantly higher in children with prior infection compared to prior vaccination.
  • Seroconversion rates for A(H3N2) were 8/8 in the prior infection group versus 3/7 in the prior vaccination group.
  • Antibody responses to A(H1N1) did not differ significantly between groups.

Conclusions:

  • Prior influenza A(H3N2) infection may be superior to vaccination in priming subsequent vaccine antibody responses against A(H3N2).
  • Findings suggest a potential difference in immunological imprinting based on the type of early influenza exposure.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.1K
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
12.3K
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
87
Cross-reactivity00:42

Cross-reactivity

Overview
28.7K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K